Arch Aesthetic Plast Surg.
2019 Apr;25(2):73-78. 10.14730/aaps.2019.01655.
Use of Abnobaviscum to treat refractory seroma after breast reconstruction with a latissimus dorsi flap: A case report
- Affiliations
-
- 1Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu, Korea. lambyang@knu.ac.kr
- 2Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Korea.
- KMID: 2449222
- DOI: http://doi.org/10.14730/aaps.2019.01655
Abstract
- In recent years, there has been a notable increase in the rate of refractory donor site seroma, defined as seroma that persists for at least 3 months postoperatively, as the number of breast reconstructions using a latissimus dorsi (LD) musculocutaneous flap has increased. Various factors have been proposed to be related, including smoking, obesity, flap mass, and body weight, and several studies have been conducted to explore treatment methods. Typically, surgical treatment, such as capsulectomy, has been considered for refractory seroma, but in this case report, we describe positive outcomes achieved by using Abnobaviscum to treat three female patients who developed a donor site seroma at least 3 months after breast reconstruction using an LD flap.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Breast reconstruction using extended latissimus dorsi muscle flap
- Efficacy of Quilting Sutures and Fibrin Sealant Together for Prevention of Seroma in Extended Latissimus Dorsi Flap Donor Sites
- Comparison of morbidity-related seroma formation following conventional latissimus dorsi flap versus muscle-sparing latissimus dorsi flap breast reconstruction
- Breast Reconstruction with the Extended Latissimus Dorsi Musculocutancous Flap
- The Safety and Cosmetic Effect of Immediate Latissimus Dorsi Flap Reconstruction after Breast Conserving Surgery
